IRMD Insider Trading Activity and SEC Form 4 Filings
IRMD insider trading summary
Over the past 12 months, insiders at Iradimed Corp (IRMD) reported 103 sales worth $17.3M by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $17.3M.
Latest IRMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Monty K Allen | Director | Sell | $88K (1,014 @ $86.44) |
| Sep 3, 2026 | Monty K Allen | Director | Sell | $35K (405 @ $86.35) |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Director | Sell | $168K (1,766 @ $95.00) |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Director | Sell | $117K (1,234 @ $95.00) |
| Jun 1, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $35K (400 @ $88.68) |
| Jun 1, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $37K (401 @ $91.08) |
| Jun 1, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $85K (924 @ $91.91) |
| Jun 1, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $70K (775 @ $89.79) |
| May 27, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $199K (2,167 @ $91.85) |
| May 27, 2026 | Roger E. Susi | CEO, President, Chairman | Sell | $31K (333 @ $92.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.